Stem cell injections
Stem cell injections in dermatology involve delivering a patient's own cells into the skin to support regeneration and healing. Typically adipose-derived or bone marrow-derived cells are used, processed to preserve viability and minimize risk. In Korea, clinics apply advanced processing and safety protocols to tailor treatments for acne scars, pigmentary concerns, and aging signs.
The injections work through paracrine signaling, growth factors, and extracellular vesicles that influence inflammation and collagen synthesis. Clinical evidence varies by condition, with stronger signals for wound repair than for pigment control, and results depend on patient factors. Careful patient selection and realistic expectations are essential for meaningful improvement.
Clinical cases in skin
Clinical cases in skin illustrate how stem cell injections complement established treatments and lasers in real patients. Acne scar remodeling, melasma, and postinflammatory hyperpigmentation have shown improvements when injections are combined with microneedling or fractional lasers. Safety considerations center on autologous sourcing, infection risk, and managing expectations around timelines.
Selecting candidates involves evaluating scar maturity and prior treatments. Clinicians stress safety, documentation, and setting realistic expectations for outcomes. Progress may take several weeks to months as collagen remodeling progresses.
Skin resurfacing trends
Skin resurfacing trends in Korea often blend laser, microneedling, and cell-based therapies to tailor regimens. Flexible protocols may combine fractional lasers with stem cell injections or conditioned media to optimize collagen remodeling. Clinicians emphasize approaching each case with a clear target, whether smoothing texture, tightening, or evening out tone.
Post-treatment care focuses on minimizing inflammation and protecting pigment balance, with guidance on sun exposure and skincare ingredients. Some programs include structured aftercare such as supervised oxygen therapy or concentrated stem cell derived filtrates to support healing. Staying informed about regulatory standards and high-quality evidence helps patients manage expectations as trend-driven options evolve.